Fig. 2: Treatment pathways to LTRA after the first episode of uncontrolled asthma in medium- and high-dose ICS/LABA cohorts. | npj Primary Care Respiratory Medicine

Fig. 2: Treatment pathways to LTRA after the first episode of uncontrolled asthma in medium- and high-dose ICS/LABA cohorts.

From: Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-/high-dose ICS/LABA

Fig. 2

a Medium-dose ICS/LABA cohort; total number of patients with uncontrolled asthma and at least 365 days of follow-up, 1933; b high-dose ICS/LABA cohort; total number of patients with uncontrolled asthma and at least 365 days of follow-up, 431. n patients with treatment pathways to LTRA, ICS inhaled corticosteroid, LABA long-acting β2-agonist, LTRA leukotriene receptor antagonist, OCS oral corticosteroid, Theo theophylline.

Back to article page